AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins
AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins
Read moreFri, 14th May 2021 08:27
AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins
Read morePhysiomics secures follow-on contract from Merck KgaA
Read moreIN BRIEF: Physiomics wins first contract from Numab Therapeutics
Read more(Sharecast News) - Consultancy firm Physiomics said on Tuesday that it has been awarded a first contract with new client Numab Therapeutics.
Read morePhysiomics says full-year results to disappoint market forecasts
Read moreAIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake
Read more(Sharecast News) - Technology-based solutions provider Physiomics said on Monday that total income for the financial year ending 30 June was likely to be below market expectations due to both Covid-19 related project delays and an increased focus on longer-term value-generating activities.
Read moreAIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes
Read moreTRADING UPDATES: CentralNic revenue doubles; Augean swing to profit
Read more(Sharecast News) - Oncology consulting company Physiomics has entered into a new agreement with clinical-stage drug development company ValiRx, it announced on Monday, superseding the agreement between the two companies, which was announced in September 2011.
Read moreIN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics
Read moreUK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand
Read more(Sharecast News) - Oncology consultancy Physiomics announced on Thursday that its existing client, Merck, has committed to an initial tranche of projects for 2021 with a total value of £0.27m.
Read moreUK TRADING UPDATE SUMMARY: Airtel Investor To Sell 60 Million Shares
Read more